Antibiotic Therapy for Pseudomonas Infections

Preferred Antibiotics

• The Infectious Diseases Society of America recommends antipseudomonal cephalosporins, such as ceftazidime or cefepime, for Pseudomonas coverage 1, 2
• The European Respiratory Society suggests that carbapenems, particularly group 2 carbapenems like imipenem/cilastatin, meropenem, and doripenem, provide activity against non-fermentative gram-negative bacilli including Pseudomonas species 1
• Piperacillin/tazobactam offers broad-spectrum activity including anti-Pseudomonas effects and anaerobic coverage, as recommended by the World Journal of Emergency Surgery 1
• Ciprofloxacin has excellent activity against Pseudomonas species and is a preferred option when oral therapy is available, according to the European Respiratory Journal 2

Combination Therapy

• The European Respiratory Society recommends combination therapy with an antipseudomonal beta-lactam plus an aminoglycoside for severe Pseudomonas infections 2
• For serious Pseudomonas infections, a beta-lactam with anti-pseudomonal activity plus an aminoglycoside is often recommended, as suggested by the European Respiratory Journal 2

Clinical Decision Making

• When treating infections where Pseudomonas putida is suspected or confirmed, the World Journal of Emergency Surgery recommends choosing one of the following options: antipseudomonal cephalosporin, carbapenem, piperacillin/tazobactam, or ciprofloxacin 1, 2